PET-imaging of 89Zr-labeled bispecific T-cell engagers in syngeneic tumor bearing mice

被引：0
|
作者：
Suurs, Frans V. [1 ]
de Groot, Derk J. [1 ]
Domanska, Urszula M. [2 ]
Lorenczewski, Grit [2 ]
Stienen, Sabine [2 ]
Friedrich, Matthias [2 ]
de Vries, Elisabeth G. [1 ]
Lub-de Hooge, Marjolijn N. [1 ]
机构：
[1] Univ Med Ctr Groningen, Groningen, Netherlands
[2] Amgen Res Munich GmbH, Munich, Germany
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-1134
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1134
引用
收藏
页数：2
相关论文
共 50 条
  • [1] PET Imaging of Acidic Tumor Environment With 89Zr-labeled pHLIP Probes
    Bauer, David
    Visca, Hannah
    Weerakkody, Anuradha
    Carter, Lukas M.
    Samuels, Zachary
    Kaminsky, Spencer
    Andreev, Oleg A.
    Reshetnyak, Yana K.
    Lewis, Jason S.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [2] PET-IMAGING OF HYPOXIA USING 89ZR-LABELED CG250-F(AB′)2
    Hoeben, B.
    Kaanders, J.
    Laverman, P.
    Oosterwijk, E.
    Oyen, W.
    Boerman, O.
    Bussink, J.
    RADIOTHERAPY AND ONCOLOGY, 2010, 94 : S7 - S7
  • [3] 89Zr-labeled nivolumab for imaging of T-cell infiltration in a humanized murine model of lung cancer
    England, Christopher G.
    Jiang, Dawei
    Ehlerding, Emily B.
    Rekoske, Brian T.
    Ellison, Paul A.
    Hernandez, Reinier
    Barnhart, Todd E.
    McNeel, Douglas G.
    Huang, Peng
    Cai, Weibo
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (01) : 110 - 120
  • [4] 89Zr-labeled nivolumab for imaging of T-cell infiltration in a humanized murine model of lung cancer
    Christopher G. England
    Dawei Jiang
    Emily B. Ehlerding
    Brian T. Rekoske
    Paul A. Ellison
    Reinier Hernandez
    Todd E. Barnhart
    Douglas G. McNeel
    Peng Huang
    Weibo Cai
    European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 110 - 120
  • [5] Molecular Design of 68Ga-and 89Zr-Labeled Anticalin Radioligands for PET-Imaging of PSMA-Positive Tumors
    Morath, Volker
    Brandt, Corinna
    Deuschle, Friedrich-Christian
    Mendler, Claudia T.
    Blechert, Birgit
    Summer, Dominik
    Barinka, Cyril
    Decristoforo, Clemens
    Weber, Wolfgang A.
    Schwaiger, Markus
    Skerra, Arne
    MOLECULAR PHARMACEUTICS, 2023, 20 (05) : 2490 - 2501
  • [6] 89Zr-labeled Bispecific T-cell Engager AMG 211 PET Shows AMG 211 Accumulation in CD3-rich Tissues and Clear, Heterogeneous Tumor Uptake
    Moek, Kirsten L.
    Waaijer, Stijn J. H.
    Kok, Iris C.
    Suurs, Frans V.
    Brouwers, Adrienne H.
    van Oordt, C. Willemien Menke-van der Houven
    Wind, Thijs T.
    Gietema, Jourik A.
    Schroder, Carolien P.
    Mahesh, Shekar V. K.
    Jorritsma-Smit, Annelies
    Lub-de Hooge, Marjolijn N.
    Fehrmann, Rudolf S. N.
    de Groot, Derk Jan A.
    de Vries, Elisabeth G. E.
    CLINICAL CANCER RESEARCH, 2019, 25 (12) : 3517 - 3527
  • [7] Preclinical tumor imaging with 89Zr-labeled monoclonal antibody ramucirumab
    Novy, Z.
    Janousek, J.
    Barta, P.
    Petrik, M.
    Hajduch, M.
    Trejtnar, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S647 - S647
  • [8] Biodistribution studies of 89Zr-labeled nanodiamonds in mice using PET and MRI
    Eberhardt, Nina
    Loeffler, Jessica
    Raabe, Marco
    Li, Hao
    Abaei, Alireza
    Herrmann, Hendrik
    Solbach, Christoph
    Weil, Tanja
    Beer, Ambros
    Rasche, Volker
    Winter, Gordon
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [9] PET Imaging of Tumor-Associated Macrophages with 89Zr-Labeled High-Density Lipoprotein Nanoparticles
    Perez-Medina, Carlos
    Tang, Jun
    Abdel-Atti, Dalya
    Hogstad, Brandon
    Merad, Miriam
    Fisher, Edward A.
    Fayad, Zahi A.
    Lewis, Jason S.
    Mulder, Willem J. M.
    Reiner, Thomas
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (08) : 1272 - 1277
  • [10] An 89Zr-Labeled PSMA Tracer for PET/CT Imaging of Prostate Cancer Patients
    Dietlein, Felix
    Kobe, Carsten
    Vazquez, Sergio Munoz
    Fischer, Thomas
    Endepols, Heike
    Hohberg, Melanie
    Reifegerst, Manuel
    Neumaier, Bernd
    Schomaecker, Klaus
    Drzezga, Alexander E.
    Dietlein, Markus
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (04) : 573 - 583
12345